Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr;21(3):511-6.
doi: 10.1097/IGC.0b013e31820cc305.

The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered?

Nadeem R Abu-Rustum  1 , Qin Zhou, Alexia Iasonos, Kaled M Alektiar, Mario M Leitao Jr, Dennis S Chi, Yukio Sonoda, Robert Soslow, Martee Hensley, Richard R Barakat
Affiliations

The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered?

Nadeem R Abu-Rustum et al. Int J Gynecol Cancer. 2011 Apr.

Abstract

Objectives: The revised 2009 International Federation of Gynecology and Obstetrics (FIGO) staging system for endometrial cancer included many changes over the 1988 system, particularly for stage I subgroups. We sought to describe the overall survival (OS) of women with stage I endometrial cancer and examine how the estimated stage-specific OS is altered in the 2009 system.

Methods: A prospectively maintained institutional endometrial database was analyzed. All patients underwent primary surgery between January 1993 and June 2009.

Results: Data from 1658 women were analyzed, including 1307 patients with FIGO 1988 stage I disease. The 5-year OS for the 1988 stages IA (92.4%), IB (87.3%), and IC (75.7%) significantly differed (P < 0.001). When patients were restaged using the 2009 system, we identified 1411 stage I patients with 5-year OS for 2009 stage IA of 89.2%, versus OS of 75.1% for IB (P = 0.001). The adjusted concordance probabilities for the 1988 stage I group and 2009 stage I group were 0.612 (SD, 0.0014) and 0.536 (SD, 0.0111), respectively.

Conclusions: The 1988 FIGO classification of stage I endometrial cancer correctly identified 3 subgroups of patients who had significantly different OS. Specifically, 1988 FIGO stages IA and IB had distinct oncologic outcomes. The revised 2009 system eliminates the most favorable group from the new classification system, and estimates of stage-specific OS for stage IB are substantially altered by the changes made in 2009. The revised system for stage I did not improve its predictive ability over the 1988 system. These data highlight the importance of developing individualized risk-prediction models and nomograms in endometrial cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The 5-year OS for 1988 FIGO stage IA (92.4%), IB (87.3%) and IC (75.7%) endometrial cancer significantly differed (P<0.001).
Figure 2
Figure 2
The 5-year OS stratified by the revised 2009 FIGO stage IA (89.2%) vs. 2009 stage IB (75.1%) endometrial cancer (P=0.001).
Figure 3
Figure 3
The 5-year OS stratified by 1988 FIGO stage IA–C and 2009 FIGO stage IA–B endometrial cancer.
See this image and copyright information in PMC

Comment in

References

    1. Boronow RC, Morrow CP, Creasman WT, Disaia PJ, Silverberg SG, Miller A, Blessing JA. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol. 1984;63:825–32. - PubMed
    1. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987;60(8 Suppl):2035–41. - PubMed
    1. DiSaia PJ, Creasman WT. Management of endometrial adenocarcinoma stage I with surgical staging followed by tailored adjuvant radiation therapy. Clin Obstet Gynaecol. 1986;13:751–65. - PubMed
    1. Gonen M, Heller G. Concordance probability and discriminatory power in proportional hazards regression. Biometrika. 2005;92:965–70.
    1. Harrell FE, Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models evaluating assumptions and adequacy, and measuring and reducing errors. Statistics in Medicine. 1996;15:361–87. - PubMed